_id
6919f1083c536f8df23185ca
Ticker
1SXP.XETRA
Name
SCHOTT Pharma AG & Co. KGaA
Exchange
XETRA
Address
Hattenbergstrasse 10, Mainz, Germany, 55122
Country
Germany
Sector
Healthcare
Industry
Medical Instruments & Supplies
Currency
EUR
Website
https://www.schott-pharma.com
Description
SCHOTT Pharma AG & Co. KGaA develops, manufactures, and sells drug containment solutions and delivery systems for injectable drugs for pharma, biotech, and life science industries worldwide. The company offers syriQ, a glass syringe for vaccines; syriQ BioPure, a glass syringe for biologics; syriQ BioPure silicone-free, a prefillable and silicone-free glass syringe for biologics; SCHOTT TOPPAC, a polymer syringe; SCHOTT TOPPAC cosmetic, a polymer syringe for aesthetic treatments; SCHOTT TOPPAC freeze, a polymer syringe for deep-cold applications; SCHOTT TOPPAC sensitive, a polymer syringe for sensitive drugs; SCHOTT TOPPAC infuse, a polymer syringe for infusion therapy; SCHOTT TOPPAC unique, a polymer container; and SCHOTT TOPPAC cartridge. It also provides pharmaceutical glass cartridge, such as cartriQ for peptide and protein-based injectables; cartriQ Large Volume for large-volume injectables; Cartridges Double Chamber for lyophilized drugs; Cartridges Break Resistant; and TopLine and StandardLine cartridges and vials. In addition, the company offers pharmaceutical glass vial, including adaptiQ for injectables; EVERIC pure for unmatched drug stability; EVERIC freeze for deep-cold applications; EVERIC care for a pH range; EVERIC strong & smooth for the filling line performance; EVERIC smart; EVERIC plus for sensitive drug formulations; and EVERIC Iyo to avoid fogging for lyophilized drugs. Further, it provides pharmaceutical glass ampoule products, comprising Ampoules easyOPC for ampoule opening; Ampoules Anti-Counterfeiting for protection against drug counterfeiting; and StandardLine ampoules. It also provides containment and drug delivery, analytics, fill-and-finish, regulatory, and sustainability services. The company was founded in 1884 and is headquartered in Mainz, Germany. SCHOTT Pharma AG & Co. KGaA operates as a subsidiary of Schott Glaswerke Beteiligungs- Und Export Gmbh.
Last Close
15.1
Volume
64497
Current Price
15.1
Change
0
Last Updated
2025-12-30T11:49:39.710Z
Image
https://logo.clearbit.com/www.schott-pharma.com
Ipo Date
-
Market Cap
2247170304
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Rating
3.83
Strong Buy
2
Buy
8
Hold
1
Sell
0
Strong Sell
1
Current Quarter
2022-09-30
Revenue
203036000
Cost Of Revenue
140313000
Gross Profit
62723000
Operating Expenses
153304000
Operating Income
49732000
Interest Expense
1088000
Pretax Income
32260000
Net Income
25584000
Eps
0.16986399248264192
Dividends Per Share
454000
Shares Outstanding
150614616
Income Tax Expense
-
EBITDA
-
Operating Margin
24.494178372308358
Total Other Income Expense Net
-
Cash
28795000
Short Term Investments
1489000
Receivables
146428000
Inventories
128936000
Total Current Assets
554516000
Property Plant Equipment
517209000
Total Assets
1196500000
Payables
99596000
Short Term Debt
-
Long Term Debt
0
Total Liabilities
487456000
Equity
707278000
Bs_currency_symbol
EUR
Depreciation
12883000
Change In Working Capital
31864000
Cash From Operations
77218000
Capital Expenditures
58861000
Cash From Investing
-
Cash From Financing
-
Net Change In Cash
2175000
Cf_currency_symbol
EUR
PE
15.3814
PB
3.215540002092529
ROE
3.61724809763629
ROA
2.1382365231926452
FCF
18357000
Fcf Percent
0.09041253767804724
Piotroski FScore
4
Health Score
54
Deep Value Investing Score
4.5
Defensive Investing Score
5.5
Dividend Investing Score
3.5
Economic Moat Investing Score
4.8
Garp Investing Score
3
Growth Investing Score
2
Momentum Investing Score
1
Net Net Investing Score
4
Quality Investing Score
7
Value Investing Score
7
Quarters > 0 > quarter
2022-09-30
Quarters > 0 > income Statement > revenue
203036000
Quarters > 0 > income Statement > cost Of Revenue
140313000
Quarters > 0 > income Statement > gross Profit
62723000
Quarters > 0 > income Statement > operating Expenses
153304000
Quarters > 0 > income Statement > operating Income
49732000
Quarters > 0 > income Statement > interest Expense
1088000
Quarters > 0 > income Statement > pretax Income
32260000
Quarters > 0 > income Statement > net Income
25584000
Quarters > 0 > income Statement > eps
0.16986399248264192
Quarters > 0 > income Statement > dividends Per Share
454000
Quarters > 0 > income Statement > shares Outstanding
150614616
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-
Quarters > 0 > income Statement > operating Margin
24.494178372308358
Quarters > 0 > income Statement > total Other Income Expense Net
-
Quarters > 0 > income Statement > currency_symbol
EUR
Quarters > 0 > balance Sheet > cash
28795000
Quarters > 0 > balance Sheet > short Term Investments
1489000
Quarters > 0 > balance Sheet > receivables
146428000
Quarters > 0 > balance Sheet > inventories
128936000
Quarters > 0 > balance Sheet > total Current Assets
554516000
Quarters > 0 > balance Sheet > property Plant Equipment
517209000
Quarters > 0 > balance Sheet > total Assets
1196500000
Quarters > 0 > balance Sheet > payables
99596000
Quarters > 0 > balance Sheet > short Term Debt
-
Quarters > 0 > balance Sheet > long Term Debt
0
Quarters > 0 > balance Sheet > total Liabilities
487456000
Quarters > 0 > balance Sheet > equity
707278000
Quarters > 0 > balance Sheet > currency_symbol
EUR
Quarters > 0 > cash Flow > net Income
25584000
Quarters > 0 > cash Flow > depreciation
12883000
Quarters > 0 > cash Flow > change In Working Capital
31864000
Quarters > 0 > cash Flow > cash From Operations
77218000
Quarters > 0 > cash Flow > capital Expenditures
58861000
Quarters > 0 > cash Flow > cash From Investing
-
Quarters > 0 > cash Flow > cash From Financing
-
Quarters > 0 > cash Flow > net Change In Cash
2175000
Quarters > 0 > cash Flow > currency_symbol
EUR
Quarters > 0 > ratios > PE
0.16986399248264192
Quarters > 0 > ratios > PB
3.215540002092529
Quarters > 0 > ratios > ROE
3.61724809763629
Quarters > 0 > ratios > ROA
2.1382365231926452
Quarters > 0 > ratios > FCF
18357000
Quarters > 0 > ratios > Piotroski FScore
4
Quarters > 0 > ratios > fcf Percent
0.09041253767804724
Quarters > 0 > health Score
54
Annuals > 0 > quarter
2024-06-30
Annuals > 0 > income Statement > revenue
957091000
Annuals > 0 > income Statement > cost Of Revenue
634481000
Annuals > 0 > income Statement > gross Profit
322610000
Annuals > 0 > income Statement > operating Expenses
767135000
Annuals > 0 > income Statement > operating Income
189956000
Annuals > 0 > income Statement > interest Expense
13487000
Annuals > 0 > income Statement > pretax Income
183971000
Annuals > 0 > income Statement > net Income
149685000
Annuals > 0 > income Statement > eps
0.9938278500142377
Annuals > 0 > income Statement > dividends Per Share
22592000
Annuals > 0 > income Statement > shares Outstanding
150614616
Annuals > 0 > income Statement > income Tax Expense
-
Annuals > 0 > income Statement > EBITDA
-
Annuals > 0 > income Statement > operating Margin
19.84722455858429
Annuals > 0 > income Statement > total Other Income Expense Net
-
Annuals > 0 > income Statement > currency_symbol
EUR
Annuals > 0 > balance Sheet > cash
23182000
Annuals > 0 > balance Sheet > short Term Investments
3249000
Annuals > 0 > balance Sheet > receivables
174888000
Annuals > 0 > balance Sheet > inventories
140445000
Annuals > 0 > balance Sheet > total Current Assets
588601000
Annuals > 0 > balance Sheet > property Plant Equipment
723490000
Annuals > 0 > balance Sheet > total Assets
1442269000
Annuals > 0 > balance Sheet > payables
95512000
Annuals > 0 > balance Sheet > short Term Debt
-
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
650000000
Annuals > 0 > balance Sheet > equity
790406000
Annuals > 0 > balance Sheet > currency_symbol
EUR
Annuals > 0 > cash Flow > net Income
149685000
Annuals > 0 > cash Flow > depreciation
64978000
Annuals > 0 > cash Flow > change In Working Capital
12820000
Annuals > 0 > cash Flow > cash From Operations
225326000
Annuals > 0 > cash Flow > capital Expenditures
145296000
Annuals > 0 > cash Flow > cash From Investing
-
Annuals > 0 > cash Flow > cash From Financing
-
Annuals > 0 > cash Flow > net Change In Cash
1241000
Annuals > 0 > cash Flow > currency_symbol
EUR
Annuals > 0 > ratios > PE
0.9938278500142377
Annuals > 0 > ratios > PB
2.850680100302882
Annuals > 0 > ratios > ROE
18.937735796540007
Annuals > 0 > ratios > ROA
10.378438418907985
Annuals > 0 > ratios > FCF
80030000
Annuals > 0 > ratios > Piotroski FScore
4
Annuals > 0 > ratios > fcf Percent
0.08361796318218435
Annuals > 0 > health Score
78
Annuals > 1 > quarter
2023-06-30
Annuals > 1 > income Statement > revenue
898602000
Annuals > 1 > income Statement > cost Of Revenue
582113000
Annuals > 1 > income Statement > gross Profit
316489000
Annuals > 1 > income Statement > operating Expenses
727679000
Annuals > 1 > income Statement > operating Income
170923000
Annuals > 1 > income Statement > interest Expense
7254000
Annuals > 1 > income Statement > pretax Income
185802000
Annuals > 1 > income Statement > net Income
151842000
Annuals > 1 > income Statement > eps
1.008149169267875
Annuals > 1 > income Statement > dividends Per Share
18878000
Annuals > 1 > income Statement > shares Outstanding
150614616
Annuals > 1 > income Statement > income Tax Expense
-
Annuals > 1 > income Statement > EBITDA
-
Annuals > 1 > income Statement > operating Margin
19.02099038283912
Annuals > 1 > income Statement > total Other Income Expense Net
-
Annuals > 1 > income Statement > currency_symbol
EUR
Annuals > 1 > balance Sheet > cash
24357000
Annuals > 1 > balance Sheet > short Term Investments
1532000
Annuals > 1 > balance Sheet > receivables
165490000
Annuals > 1 > balance Sheet > inventories
138943000
Annuals > 1 > balance Sheet > total Current Assets
468338000
Annuals > 1 > balance Sheet > property Plant Equipment
637805000
Annuals > 1 > balance Sheet > total Assets
1231828000
Annuals > 1 > balance Sheet > payables
90644000
Annuals > 1 > balance Sheet > short Term Debt
-
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
539649000
Annuals > 1 > balance Sheet > equity
690431000
Annuals > 1 > balance Sheet > currency_symbol
EUR
Annuals > 1 > cash Flow > net Income
151842000
Annuals > 1 > cash Flow > depreciation
51848000
Annuals > 1 > cash Flow > change In Working Capital
-13703000
Annuals > 1 > cash Flow > cash From Operations
181652000
Annuals > 1 > cash Flow > capital Expenditures
175524000
Annuals > 1 > cash Flow > cash From Investing
-
Annuals > 1 > cash Flow > cash From Financing
-
Annuals > 1 > cash Flow > net Change In Cash
-1154000
Annuals > 1 > cash Flow > currency_symbol
EUR
Annuals > 1 > ratios > PE
1.008149169267875
Annuals > 1 > ratios > PB
3.2634610197977785
Annuals > 1 > ratios > ROE
21.992349706198013
Annuals > 1 > ratios > ROA
12.32655857798329
Annuals > 1 > ratios > FCF
6128000
Annuals > 1 > ratios > Piotroski FScore
4
Annuals > 1 > ratios > fcf Percent
0.0068194818173117795
Annuals > 1 > health Score
66
Annuals > 2 > quarter
2022-06-30
Annuals > 2 > income Statement > revenue
821144000
Annuals > 2 > income Statement > cost Of Revenue
524717000
Annuals > 2 > income Statement > gross Profit
296427000
Annuals > 2 > income Statement > operating Expenses
651807000
Annuals > 2 > income Statement > operating Income
169337000
Annuals > 2 > income Statement > interest Expense
2686000
Annuals > 2 > income Statement > pretax Income
158288000
Annuals > 2 > income Statement > net Income
125379000
Annuals > 2 > income Statement > eps
0.8324490898014838
Annuals > 2 > income Statement > dividends Per Share
11456000
Annuals > 2 > income Statement > shares Outstanding
150614616
Annuals > 2 > income Statement > income Tax Expense
-
Annuals > 2 > income Statement > EBITDA
-
Annuals > 2 > income Statement > operating Margin
20.62208333739271
Annuals > 2 > income Statement > total Other Income Expense Net
-
Annuals > 2 > income Statement > currency_symbol
EUR
Annuals > 2 > balance Sheet > cash
28795000
Annuals > 2 > balance Sheet > short Term Investments
1489000
Annuals > 2 > balance Sheet > receivables
146428000
Annuals > 2 > balance Sheet > inventories
128936000
Annuals > 2 > balance Sheet > total Current Assets
554516000
Annuals > 2 > balance Sheet > property Plant Equipment
517209000
Annuals > 2 > balance Sheet > total Assets
1196500000
Annuals > 2 > balance Sheet > payables
99596000
Annuals > 2 > balance Sheet > short Term Debt
-
Annuals > 2 > balance Sheet > long Term Debt
0
Annuals > 2 > balance Sheet > total Liabilities
487456000
Annuals > 2 > balance Sheet > equity
707278000
Annuals > 2 > balance Sheet > currency_symbol
EUR
Annuals > 2 > cash Flow > net Income
125379000
Annuals > 2 > cash Flow > depreciation
55357000
Annuals > 2 > cash Flow > change In Working Capital
1600000
Annuals > 2 > cash Flow > cash From Operations
182123000
Annuals > 2 > cash Flow > capital Expenditures
152688000
Annuals > 2 > cash Flow > cash From Investing
-
Annuals > 2 > cash Flow > cash From Financing
-
Annuals > 2 > cash Flow > net Change In Cash
-2394000
Annuals > 2 > cash Flow > currency_symbol
EUR
Annuals > 2 > ratios > PE
0.8324490898014838
Annuals > 2 > ratios > PB
3.1857270484307443
Annuals > 2 > ratios > ROE
17.726975814319122
Annuals > 2 > ratios > ROA
10.47881320518178
Annuals > 2 > ratios > FCF
29435000
Annuals > 2 > ratios > Piotroski FScore
4
Annuals > 2 > ratios > fcf Percent
0.03584633145952476
Annuals > 2 > health Score
67
Annuals > 3 > quarter
2021-06-30
Annuals > 3 > income Statement > revenue
648668000
Annuals > 3 > income Statement > cost Of Revenue
422499000
Annuals > 3 > income Statement > gross Profit
226169000
Annuals > 3 > income Statement > operating Expenses
533419000
Annuals > 3 > income Statement > operating Income
115249000
Annuals > 3 > income Statement > interest Expense
1674000
Annuals > 3 > income Statement > pretax Income
123284000
Annuals > 3 > income Statement > net Income
100753000
Annuals > 3 > income Statement > eps
0.668945701790323
Annuals > 3 > income Statement > dividends Per Share
39824000
Annuals > 3 > income Statement > shares Outstanding
150614616
Annuals > 3 > income Statement > income Tax Expense
-
Annuals > 3 > income Statement > EBITDA
-
Annuals > 3 > income Statement > operating Margin
17.767024117113838
Annuals > 3 > income Statement > total Other Income Expense Net
-
Annuals > 3 > income Statement > currency_symbol
EUR
Annuals > 3 > balance Sheet > cash
27859000
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
117616000
Annuals > 3 > balance Sheet > inventories
83517000
Annuals > 3 > balance Sheet > total Current Assets
302157000
Annuals > 3 > balance Sheet > property Plant Equipment
334139000
Annuals > 3 > balance Sheet > total Assets
739895000
Annuals > 3 > balance Sheet > payables
63376000
Annuals > 3 > balance Sheet > short Term Debt
-
Annuals > 3 > balance Sheet > long Term Debt
0
Annuals > 3 > balance Sheet > total Liabilities
320477000
Annuals > 3 > balance Sheet > equity
417963000
Annuals > 3 > balance Sheet > currency_symbol
EUR
Annuals > 3 > cash Flow > net Income
100753000
Annuals > 3 > cash Flow > depreciation
36444000
Annuals > 3 > cash Flow > change In Working Capital
744000
Annuals > 3 > cash Flow > cash From Operations
132213000
Annuals > 3 > cash Flow > capital Expenditures
98628000
Annuals > 3 > cash Flow > cash From Investing
-
Annuals > 3 > cash Flow > cash From Financing
-
Annuals > 3 > cash Flow > net Change In Cash
8816000
Annuals > 3 > cash Flow > currency_symbol
EUR
Annuals > 3 > ratios > PE
0.668945701790323
Annuals > 3 > ratios > PB
5.390895020276915
Annuals > 3 > ratios > ROE
24.105722276852255
Annuals > 3 > ratios > ROA
13.617202440886883
Annuals > 3 > ratios > FCF
33585000
Annuals > 3 > ratios > Piotroski FScore
4
Annuals > 3 > ratios > fcf Percent
0.051775330369310646
Annuals > 3 > health Score
71
Valuation > metrics > PE
15.3814
Valuation > metrics > PB
3.215540002092529
Valuation > final Score
77.84459997907472
Valuation > verdict
3.6% Overvalued
Profitability > metrics > ROE
3.61724809763629
Profitability > metrics > ROA
4.613753255090926
Profitability > metrics > Net Margin
0.12600721054394295
Profitability > final Score
40
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.6892000033932909
Risk > metrics > Interest Coverage
45.70955882352941
Risk > final Score
88
Risk > verdict
Low
Liquidity > metrics > Current Ratio
5.567653319410418
Liquidity > metrics > Quick Ratio
4.273063175227921
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
0
Prev Valuations > 1
0
Prev Valuations > 2
0
Prev Profitabilities > 0
0
Prev Profitabilities > 1
0
Prev Profitabilities > 2
0
Prev Risks > 0
0
Prev Risks > 1
0
Prev Risks > 2
0
Prev Liquidities > 0
0
Prev Liquidities > 1
0
Prev Liquidities > 2
0
Updated At
2026-01-22T21:21:31.595Z
Earnings History > 0 > period
2026-03-31
Earnings History > 0 > report Date
2026-05-13
Earnings History > 0 > date
2026-03-31
Earnings History > 0 > before After Market
BeforeMarket
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-
Earnings History > 0 > eps Estimate
-
Earnings History > 0 > eps Difference
0
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2025-12-31
Earnings History > 1 > report Date
2026-02-11
Earnings History > 1 > date
2025-12-31
Earnings History > 1 > before After Market
AfterMarket
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
0
Earnings History > 1 > eps Estimate
0.17
Earnings History > 1 > eps Difference
-0.17
Earnings History > 1 > surprise Percent
-100
Earnings History > 2 > period
2025-09-30
Earnings History > 2 > report Date
2025-12-11
Earnings History > 2 > date
2025-09-30
Earnings History > 2 > before After Market
AfterMarket
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
0.22
Earnings History > 2 > eps Estimate
0.24
Earnings History > 2 > eps Difference
-0.02
Earnings History > 2 > surprise Percent
-8.3333
Earnings History > 3 > period
2025-06-30
Earnings History > 3 > report Date
2025-08-12
Earnings History > 3 > date
2025-06-30
Earnings History > 3 > before After Market
BeforeMarket
Earnings History > 3 > currency
EUR
Earnings History > 3 > eps Actual
0.3
Earnings History > 3 > eps Estimate
0.29
Earnings History > 3 > eps Difference
0.01
Earnings History > 3 > surprise Percent
3.4483
Earnings History > 4 > period
2025-03-31
Earnings History > 4 > report Date
2025-05-14
Earnings History > 4 > date
2025-03-31
Earnings History > 4 > before After Market
AfterMarket
Earnings History > 4 > currency
EUR
Earnings History > 4 > eps Actual
0.26
Earnings History > 4 > eps Estimate
0.24
Earnings History > 4 > eps Difference
0.02
Earnings History > 4 > surprise Percent
8.3333
Earnings History > 5 > period
2024-12-31
Earnings History > 5 > report Date
2025-02-13
Earnings History > 5 > date
2024-12-31
Earnings History > 5 > before After Market
BeforeMarket
Earnings History > 5 > currency
-
Earnings History > 5 > eps Actual
0.19
Earnings History > 5 > eps Estimate
0.19
Earnings History > 5 > eps Difference
0
Earnings History > 5 > surprise Percent
0
Earnings History > 6 > period
2024-09-30
Earnings History > 6 > report Date
2024-12-12
Earnings History > 6 > date
2024-09-30
Earnings History > 6 > before After Market
BeforeMarket
Earnings History > 6 > currency
EUR
Earnings History > 6 > eps Actual
0.22
Earnings History > 6 > eps Estimate
0.244
Earnings History > 6 > eps Difference
-0.024
Earnings History > 6 > surprise Percent
-9.8361
Earnings History > 7 > period
2024-06-30
Earnings History > 7 > report Date
2024-08-29
Earnings History > 7 > date
2024-06-30
Earnings History > 7 > before After Market
BeforeMarket
Earnings History > 7 > currency
EUR
Earnings History > 7 > eps Actual
0.31
Earnings History > 7 > eps Estimate
0.2
Earnings History > 7 > eps Difference
0.11
Earnings History > 7 > surprise Percent
55
Earnings History > 8 > period
2024-03-31
Earnings History > 8 > report Date
2024-06-27
Earnings History > 8 > date
2024-03-31
Earnings History > 8 > before After Market
BeforeMarket
Earnings History > 8 > currency
EUR
Earnings History > 8 > eps Actual
0.1662
Earnings History > 8 > eps Estimate
0.21
Earnings History > 8 > eps Difference
-0.0438
Earnings History > 8 > surprise Percent
-20.8571
Earnings History > 9 > period
2023-12-31
Earnings History > 9 > report Date
2024-03-01
Earnings History > 9 > date
2023-12-31
Earnings History > 9 > before After Market
BeforeMarket
Earnings History > 9 > currency
EUR
Earnings History > 9 > eps Actual
0.29
Earnings History > 9 > eps Estimate
0.26
Earnings History > 9 > eps Difference
0.03
Earnings History > 9 > surprise Percent
11.5385
Earnings History > 10 > period
2023-09-30
Earnings History > 10 > report Date
2023-11-29
Earnings History > 10 > date
2023-09-30
Earnings History > 10 > before After Market
-
Earnings History > 10 > currency
EUR
Earnings History > 10 > eps Actual
0.1639
Earnings History > 10 > eps Estimate
0.1422
Earnings History > 10 > eps Difference
0.0217
Earnings History > 10 > surprise Percent
15.2602
Earnings History > 11 > period
2023-06-30
Earnings History > 11 > report Date
2023-08-30
Earnings History > 11 > date
2023-06-30
Earnings History > 11 > before After Market
-
Earnings History > 11 > currency
EUR
Earnings History > 11 > eps Actual
0.2007
Earnings History > 11 > eps Estimate
0.2
Earnings History > 11 > eps Difference
0.0007
Earnings History > 11 > surprise Percent
0.35
SCHOTT Pharma AG & Co. KGaA develops, manufactures, and sells drug containment solutions and delivery systems for injectable drugs for pharma, biotech, and life science industries worldwide. The company offers syriQ, a glass syringe for vaccines; syriQ BioPure, a glass syringe for biologics; syriQ BioPure silicone-free, a prefillable and silicone-free glass syringe for biologics; SCHOTT TOPPAC, a polymer syringe; SCHOTT TOPPAC cosmetic, a polymer syringe for aesthetic treatments; SCHOTT TOPPAC freeze, a polymer syringe for deep-cold applications; SCHOTT TOPPAC sensitive, a polymer syringe for sensitive drugs; SCHOTT TOPPAC infuse, a polymer syringe for infusion therapy; SCHOTT TOPPAC unique, a polymer container; and SCHOTT TOPPAC cartridge. It also provides pharmaceutical glass cartridge, such as cartriQ for peptide and protein-based injectables; cartriQ Large Volume for large-volume injectables; Cartridges Double Chamber for lyophilized drugs; Cartridges Break Resistant; and TopLine and StandardLine cartridges and vials. In addition, the company offers pharmaceutical glass vial, including adaptiQ for injectables; EVERIC pure for unmatched drug stability; EVERIC freeze for deep-cold applications; EVERIC care for a pH range; EVERIC strong & smooth for the filling line performance; EVERIC smart; EVERIC plus for sensitive drug formulations; and EVERIC Iyo to avoid fogging for lyophilized drugs. Further, it provides pharmaceutical glass ampoule products, comprising Ampoules easyOPC for ampoule opening; Ampoules Anti-Counterfeiting for protection against drug counterfeiting; and StandardLine ampoules. It also provides containment and drug delivery, analytics, fill-and-finish, regulatory, and sustainability services. The company was founded in 1884 and is headquartered in Mainz, Germany. SCHOTT Pharma AG & Co. KGaA operates as a subsidiary of Schott Glaswerke Beteiligungs- Und Export Gmbh.
Stock Price
€0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/A(Last Updated 2022-09-30)
Rating:
BUY
$
Analyst Picks
Strong Buy
2
Buy
8
Hold
1
Sell
0
Strong Sell
1
(Last Updated 2022-09-30)
Health Score
Price to Earnings Ratio (P/E)
-
Very High
Low ≥ 50
High ≤ 10
Price to Book Ratio (P/B)
-
Very High
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Medium
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
Medium
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of SCHOTT Pharma AG & Co. KGaA
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
2025-12-31
EPS Estimate
0.17
Date
2025-09-30
EPS Actual
0.22
EPS Estimate
0.24
EPS Difference
-0.02
Surprise Percent
-8.3333%
(Last Updated 2022-09-30)
(Last Updated 2022-09-30)
Revenue
€ 0
Cost Of Revenue
€ 0
Gross Profit
€ 0
Operating Expenses
€ 0
Operating Income
€ 0
Interest Expense
€ 0
Pretax Income
€ 0
Net Income
€ 0
Income Tax Expense
€ 0
EBITDA
€ 0
Total Other Income Expense Net
€ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2022-09-30)
Cash
€ 0
Short Term Investments
€ 0
Receivables
€ 0
Inventories
€ 0
Total Current Assets
€ 0
Property Plant Equipment
€ 0
Total Assets
€ 0
Payables
€ 0
Short Term Debt
€ 0
Long Term Debt
€ 0
Total Liabilities
€ 0
Equity
€ 0
(Last Updated 2022-09-30)
Net Income
€ 0
Depreciation
€ 0
Change In Working Capital
€ 0
Cash From Operations
€ 0
Capital Expenditures
€ 0
Cash From Investing
€ 0
Cash From Financing
€ 0
Net Change In Cash
€ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.